- Home
- ACIU vs WBX Comparison
ACIU vs WBX Comparison
Compare ACIU & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | WBX |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | Switzerland | Spain |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.6M | 63.8M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACIU | WBX |
|---|---|---|
| Price | $2.51 | $2.80 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $8.54 | $4.00 |
| AVG Volume (30 Days) | ★ 177.0K | 12.3K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $422.39 | N/A |
| Revenue Next Year | $377.85 | $142.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $2.30 |
| 52 Week High | $4.00 | $7.60 |
Technical Indicators
Market Signals| Indicator | ACIU | WBX |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 42.51 |
| Support Level | $2.13 | $2.64 |
| Resistance Level | $2.96 | $3.12 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 19.92 | 54.10 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.